Treatment with the soluble guanylate cyclase activator BAY 60-2770 restores in vitro bladder contractile responses in a rat model of chronic prostatitis
Aim:: Examine how innate bladder contractility and corresponding receptor expression was affected by chronic prostatitis (CP) and how treatment with the soluble guanylate cyclase (sGC) activator BAY 60-2770 influenced this. Methods:: To create a functional model for CP, 24 male Sprague-Dawley rats w...
Main Authors: | Ozgu Aydogdu, Fernando Perez, Jan Rataj, Felicia Nilsson, Patrik Aronsson, Thomas Carlsson, Peter Sandner, Bhavik Patel, Gunnar Tobin, Michael Winder |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Continence |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772973722009961 |
Similar Items
-
23 THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR BAY 60-2770 RESTORES PURINOCEPTOR-INDUCED BLADDER CONTRACTIONS IN A RAT MODEL OF CHRONIC PROSTATITIS
by: O Aydogdu, et al.
Published: (2022-06-01) -
Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide
by: Patrik Aronsson, et al.
Published: (2023-09-01) -
Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion
by: Eric H. Mace, et al.
Published: (2023-07-01) -
The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system
by: Susana S. Correia, et al.
Published: (2021-09-01) -
Soluble Guanylate Cyclase β1 Subunit Represses Human Glioblastoma Growth
by: Haijie Xiao, et al.
Published: (2023-03-01)